Get an alert when ALERE TECHNOLOGIES LIMITED files next

Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.

Free · confirmation link first · unsubscribe in one click

Next accounts due

2026-09-30 (in 4mo)

Last filed for 2024-12-31

Confirmation statement due

2027-02-13 (in 9mo)

Last made up 2026-01-30

Watchouts

None on the register

Cash

Latest balance sheet

Net assets

-£26M

-5.5% vs 2023

Employees

0

Average over period

Profit before tax

-£1M

-14.9% vs 2023

Accounts

2-year trend · latest reflected 2024-12-31

Metric Trend 2023-12-312024-12-31
Turnover
Operating profit -£16,490-£17,084
Profit before tax -£1,196,662-£1,374,987
Net profit -£1,196,662-£1,374,987
Cash
Total assets less current liabilities
Net assets -£24,970,490-£26,345,477
Equity -£24,970,490-£26,345,477
Average employees 00
Wages
Directors' remuneration £0£0

Values shown as filed in the company's annual accounts. indicates the figure wasn't present under that line item in that period. About these numbers

Year-on-year

FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31

Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers

Ratios

Computed from the line items above — sparklines read oldest → newest

Ratio Trend 2023-12-312024-12-31
Gearing (liabilities / total assets) 15884.5%18821.8%
Current ratio 0.01x0.01x
Interest cover -0.01x-0.01x

Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

Name history

Renamed 4 times since incorporation

  1. ALERE TECHNOLOGIES LIMITED 2010-03-26 → present
  2. STIRLING MEDICAL INNOVATIONS LIMITED 2005-02-25 → 2010-03-26
  3. CARDIOSURE LIMITED 2005-02-24 → 2005-02-25
  4. CARDIOSENSE LTD. 2005-01-31 → 2005-02-24
  5. QUILLCO 185 LIMITED 2004-12-06 → 2005-01-31

Audit & accounting basis

Accounting basis
FRS 102
Reporting scope
Standalone (parent only)
Auditor
Ernst & Young
Audit opinion
Unqualified (clean)
Going concern
Affirmed

“The company incurred a net loss and net liabilities, but the ultimate parent company, Abbott Laboratories, provided a letter of support to meet its liabilities for 12 months. The director believes no material uncertainty exists and continues to adopt the going concern basis.”

Significant events

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

People

1 active · 20 resigned

Name Role Appointed Born Nationality
BOND, David Andrew Director 2024-06-10 Sep 1971 British
Show 20 resigned officers
Name Role Appointed Resigned
COULING, Geoffrey Secretary 2008-06-10 2017-10-03
HANNAH, Thomas Douglas Secretary 2005-04-06 2008-06-10
POLKA, Hazel Nadyezhda Secretary 2005-02-24 2005-04-06
QUILL SERVE LIMITED Corporate Nominee Secretary 2004-12-06 2005-02-24
BAIRD, Graeme Director 2011-07-19 2013-04-15
BARRY, Douglas John Director 2015-09-29 2017-10-03
DENNISON, Manus Director 2010-08-09 2014-06-13
FALLON, Kevin Director 2011-08-19 2015-02-20
FELLOWS, Trevor Director 2017-10-03 2024-06-10
HANNAH, Douglas Director 2015-02-20 2015-12-31
HUTCHISON, Robert Director 2005-04-06 2008-06-09
LANG, David Director 2007-09-26 2011-07-19
MCALEER, Jerome Francis Director 2005-02-24 2014-07-14
MCNICOL, Marcia Elizabeth Director 2014-06-13 2015-02-20
SAUNDERS, Callum Director 2013-04-15 2015-02-20
SCOTT, David, Dr Director 2005-02-24 2014-07-14
TEITEL, David Director 2014-10-03 2015-09-29
WILSON, Stewart Director 2015-02-20 2017-12-01
YOOR, Brian Bernard Director 2017-10-03 2018-08-01
QUILL FORM LIMITED Corporate Nominee Director 2004-12-06 2005-02-24

Ownership

Persons with significant control

Name Kind Nature of control Notified Status
Abbott Laboratories Corporate entity Shares 75–100%, Voting 75–100%, Appoints directors 2017-10-03 Active
Alere Switzerland Gmbh Corporate entity Shares 75–100% 2016-04-06 Active

Filing timeline

Last 20 of 107 total filings

Date Type Category Description
2026-02-10 CS01 confirmation-statement Confirmation statement with no updates PDF
2025-06-13 AA accounts Accounts with accounts type full
2025-02-06 PSC05 persons-with-significant-control Change to a person with significant control PDF
2025-02-05 CS01 confirmation-statement Confirmation statement with updates PDF
2025-01-31 CS01 confirmation-statement Confirmation statement with updates PDF
2025-01-31 PSC05 persons-with-significant-control Change to a person with significant control PDF
2024-07-08 AA accounts Accounts with accounts type full
2024-06-13 AP01 officers Appoint person director company with name date PDF
2024-06-13 TM01 officers Termination director company with name termination date PDF
2024-02-02 CS01 confirmation-statement Confirmation statement with no updates PDF
2023-10-03 AA accounts Accounts with accounts type full
2023-02-01 CS01 confirmation-statement Confirmation statement with no updates PDF
2022-09-02 AA accounts Accounts with accounts type full
2022-01-11 CS01 confirmation-statement Confirmation statement with no updates PDF
2021-09-27 AA accounts Accounts with accounts type full
2021-03-24 PSC02 persons-with-significant-control Notification of a person with significant control PDF
2021-03-23 AD02 address Change sail address company with old address new address PDF
2021-03-23 CS01 confirmation-statement Confirmation statement with no updates PDF
2020-09-23 AA accounts Accounts with accounts type full
2020-01-16 AD03 address Move registers to sail company with new address PDF

Public-record activity

Raw counts from Companies House — last 12–24 months

Filings
2

last 12 months

Capital events
0

last 24 months

Officers appointed
0

last 12 months

Officers resigned
0

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.

Official Companies House page